Evotec
Anna Costa is an accomplished financial professional with extensive experience in various financial roles. Currently serving as Senior Group Business Controller at Evotec since September 2018, Anna has progressed through multiple positions including Global Controller and Financial Controller & Business Support. Prior to Evotec, Anna worked as a Business Controller at Uteco Group, focusing on monthly economic reporting and margin analysis. Anna's career began at PwC, where responsibilities included auditing financial statements and internal control assessments for industrial clients. Earlier experience includes a strategic analysis internship at Michelin. Anna holds a degree in Economics and Business Management from Università degli Studi di Padova and has pursued further education at Western Michigan University and Clermont School of Business.
This person is not in any teams
This person is not in any offices
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.